Table 3 Pulmonary complications
| Â | Whole cohort | Control | Study | t-test | p value |
|---|---|---|---|---|---|
N = 50 | n = 26 | n = 24 | |||
Pulmonary complications | Â | Â | Â | 11.538 | .001* |
 No | 22 (44%) | 5 (19.2%) | 17 (70.8%) |  |  |
 Yes | 28 (56%) | 21 (80.7%) | 7 (29.2%) |  |  |
Pneumothorax | Â | Â | Â | 0.942 | .332 |
 No | 49 (98%) | 25 (96.2%) | 24 (100%) |  |  |
 Yes | 1 (2%) | 1 (3.8%) | 0 |  |  |
Hemothorax | Â | Â | Â | 8.013 | .005* |
 No | 25 (50%) | 8 (30.8%) | 17 (70.8%) |  |  |
 Yes | 25 (50%) | 18 (69.2%) | 7 (29.2%) |  |  |
Pneumonia | |||||
 No | 50 (100%) | 26 (100%) | 24 (100%) |  |  |
 Yes | 0 | 0 | 0 |  |  |
Atelectasis | Â | Â | Â | 1.923 | .166 |
 No | 48 (96%) | 24 (92.3%) | 24 (100%) |  |  |
 Yes | 2 (4%) | 2 (7.7%) | 0 |  |  |
Tube thoracostomy | 5 (10%) | 5 (19.2%) | 0 | 5.128 | .051 |